George Tsokos, MD.

Professor of Medicine at Harvard Medical School and on staff at Beth Israel Deaconess Medical Center, Harvard Medical School. He served on the Boards of Directors of the Research for the Lupus Foundation of America and serves as a member of the Scientific Advisory Board of the Alliance for Lupus Research.

John Gordon, PhD. 

Professor, Critical Care, Department of Medicine, University of Saskatchewan, Canada. He is the Vice-president of the Canadian Society for Immunology, and has served on the Boards, management or review committees of the Gairdner Foundation, AllerGen NCE and the CIHR Immunol & Transplantation grant panel among others. 

Chaim Putterman, MD. 

Professor, Department of Medicine, Albert Einstein College of Medicine, USA. Dr. Putterman is a clinical rheumatologist who has published more than 200 articles and book chapters in the medical and scientific literature for lupus and arthritis. He was elected to the American Society of Clinical Investigation, and is a member of the American College of Rheumatology and the American Association of Immunologists. Dr. Putterman has served on multiple NIH and international study sections, and is currently a member of several editorial boards.

Willem van Eden, MD. 

Author of more than 240 scientific papers, among which a 1988 paper in Nature was among the top-100 most cited papers worldwide. He is the Receiving Editor for Cell Stress & Chaperones: Stress and Immunity Section Editor and FEMS Immunol. Med. Microbiol.

David Wofsy, MD.

Physician and Professor, UCSF, USA. Dr. Wofsy is a Professor of Medicine and Microbiology/Immunology at UCSF and serves as Associate Dean for Admissions for the UCSF School of Medicine. He has served on numerous NIH study sections, and on the Arthritis Advisory Committee of the Food and Drug Administration. Dr. Wofsy is a past-President of the American College of Rheumatology. 

Caroline Jefferies, PhD.

Associate Professor, Cedars-Sinai Department of Medicine, Division of Rheumatology, USA. Dr. Jefferies has an extensive history of research on innate immune response pathways and myeloid cells in SLE. Her work has led to the identification of TRIM21 has a primary regulator of IFN I and IL-23 production, and has translated that work in the lupus setting. Her work is funded by the Alliance for Lupus Research.